{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:24:05Z","timestamp":1773959045145,"version":"3.50.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00704-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T03:21:22Z","timestamp":1761189682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon"],"prefix":"10.1186","volume":"20","author":[{"given":"Ikponmwosa Jude","family":"Ogieuhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Oluwatomiwa","family":"Ajekiigbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinonyelum Emmanuel","family":"Agbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidera Stanley","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adegbesan Abiodun","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Chinaecherem","family":"Onyehalu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercy Chisom","family":"Agu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia Mmesomachi","family":"Mbaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adewunmi","family":"Akingbola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bisharat","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owa","family":"Ogieuhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olufemi","family":"Akinmeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"11","key":"704_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","volume":"52","author":"CA Pollard","year":"2020","unstructured":"Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020;52(11):549\u201357.","journal-title":"Physiol Genomics"},{"key":"704_CR2","unstructured":"datadot [Internet]. [cited 2024 Dec 8]. COVID-19 cases | WHO COVID-19 dashboard. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases"},{"issue":"9","key":"704_CR3","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.4103\/jfmpc.jfmpc_1570_21","volume":"11","author":"N Moslehi","year":"2022","unstructured":"Moslehi N, Jahromy MH, Ashrafi P, Vatani K, Nemati MAH, Moghadam PA, et al. Multi-organ system involvement in coronavirus disease 2019 (COVID-19): A mega review. J Family Med Prim Care. 2022;11(9):5014\u201323.","journal-title":"J Family Med Prim Care"},{"issue":"3","key":"704_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"704_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/00000658-195609000-00007","volume":"144","author":"TC Everson","year":"1956","unstructured":"Everson TC, Cole WH. Spontaneous regression of cancer: preliminary report. Ann Surg. 1956;144(3):366\u201380.","journal-title":"Ann Surg"},{"issue":"1","key":"704_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jons.2016.04.008","volume":"2","author":"T Salman","year":"2016","unstructured":"Salman T. Spontaneous tumor regression. J Oncological Sci. 2016;2(1):1\u20134.","journal-title":"J Oncological Sci"},{"issue":"2","key":"704_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3121\/cmr.2.2.85","volume":"2","author":"DM Elston","year":"2004","unstructured":"Elston DM. Mechanisms of regression. Clin Med Res. 2004;2(2):85\u20138.","journal-title":"Clin Med Res"},{"issue":"2","key":"704_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/0284186X.2012.711954","volume":"52","author":"AH K\u00f8stner","year":"2013","unstructured":"K\u00f8stner AH, Johansen RF, Schmidt H, M\u00f8lle I. Regression in cancer following fever and acute infection. Acta Oncol. 2013;52(2):455\u20137.","journal-title":"Acta Oncol"},{"issue":"4","key":"704_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/CAD.0000000000000337","volume":"27","author":"P Kucerova","year":"2016","unstructured":"Kucerova P, Cervinkova M. Spontaneous regression of tumour and the role of microbial infection \u2013 possibilities for cancer treatment. Anticancer Drugs. 2016;27(4):269\u201377.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"704_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-023-04110-w","volume":"21","author":"C Meo","year":"2023","unstructured":"Meo C, Palma G, Bruzzese F, Budillon A, Napoli C, de Nigris F. Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment. J Translational Med. 2023;21(1):273.","journal-title":"J Translational Med"},{"issue":"2","key":"704_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23(2):186\u201393.","journal-title":"Nat Immunol"},{"issue":"2","key":"704_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijrobp.2020.06.056","volume":"108","author":"MF Gensheimer","year":"2020","unstructured":"Gensheimer MF, Yom SS, Soto N, Dignam JJ, Le QT, Machtay M, Curran WJ. Multicenter clinical cancer research after COVID-19: A perspective from NRG oncology. Int J Radiat Oncol Biol Phys. 2020;108(2):483\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"704_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12192-021-01211-7","volume":"26","author":"S Burgio","year":"2021","unstructured":"Burgio S, Conway de Macario E, Macario AJ, Cappello F. SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity. Cell Stress Chaperones. 2021;26(4):611\u20136.","journal-title":"Cell Stress Chaperones"},{"key":"704_CR14","doi-asserted-by":"crossref","unstructured":"Bounassar-Filho JP, Boeckler-Troncoso L, Cajigas-Gonzalez J, Zavala-Cerna MG. SARS-CoV-2 as an oncolytic virus following reactivation of the immune system: a review. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032326"},{"issue":"October","key":"704_CR15","first-page":"1","volume":"15","author":"S Deng","year":"2024","unstructured":"Deng S, Xu Z, Hu J, Yang Y, Zhu F, Liu Z, et al. The molecular mechanisms of CD8\u2009+\u2009T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions. Front Immunol. 2024;15(October):1\u201317.","journal-title":"Front Immunol"},{"key":"704_CR16","doi-asserted-by":"crossref","unstructured":"de Sousa LG, Mcgrail DJ, Li K, Marques-Piubelli ML, Gonzalez C, Dai H, et al. Spontaneous tumor regression following COVID-19 vaccination. J Immunother Cancer. 2022;10(3).","DOI":"10.1136\/jitc-2021-004371"},{"issue":"1\u20132","key":"704_CR17","first-page":"259","volume":"13","author":"D Ahmed","year":"2021","unstructured":"Ahmed D, Ramla S, Muhammad N, Tahir Y, Habib B. Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells? Ther Adv Vaccines. 2021;13(1\u20132):259\u201361.","journal-title":"Ther Adv Vaccines"},{"key":"704_CR18","doi-asserted-by":"crossref","unstructured":"Silva MJA, Rodrigues YC, Lima KVB, Lima LNGC. Innate immunity to SARS-CoV-2 infection: a review. Epidemiol Infect. 2022;150.","DOI":"10.1017\/S095026882200125X"},{"key":"704_CR19","doi-asserted-by":"crossref","unstructured":"Fielding CA, Sabberwal P, Williamson JC, Greenwood EJD, Crozier TWM, Zelek W, et al. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. Elife. 2022;11.","DOI":"10.7554\/eLife.74489"},{"issue":"3","key":"704_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.17116","volume":"192","author":"S Challenor","year":"2021","unstructured":"Challenor S, Tucker D. SARS-CoV-2-induced remission of hodgkin lymphoma. Br J Haematol. 2021;192(3):415.","journal-title":"Br J Haematol"},{"issue":"17","key":"704_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176351","volume":"21","author":"C van Eeden","year":"2020","unstructured":"van Eeden C, Khan L, Osman MS, Tervaert JWC. Natural killer cell dysfunction and its role in COVID-19. Int J Mol Sci. 2020;21(17):1\u201317.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"704_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2024.14302","volume":"27","author":"X Zhang","year":"2024","unstructured":"Zhang X, Chen J, Sun J, Gao S, Zhao F, Qian N. Tumor reduction after SARS\u2013CoV\u20132 infection in a patient with lung cancer: A case report. Oncol Lett. 2024;27(4):1\u20135.","journal-title":"Oncol Lett"},{"key":"704_CR23","doi-asserted-by":"crossref","unstructured":"Choong OK, Id RJ, Bergdahl AG, Brunet S. SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma. PLoS ONE. 2023;1\u201312.","DOI":"10.1371\/journal.pone.0279578"},{"key":"704_CR24","unstructured":"New research sheds light on. a surprising connection between COVID-19 and cancer regression [Internet]. [cited 2024 Dec 9]. Available from: https:\/\/news.nm.org\/new-research-sheds-light-on-a-surprising-connection-between-covid-19-and-cancer-regression\/"},{"issue":"3","key":"704_CR25","first-page":"1","volume":"91","author":"F Pasin","year":"2020","unstructured":"Pasin F, Calveri MM, Pizzarelli G, Calabrese A, Andreoli M, Bongiovanni I, et al. Oncolytic effect of SARS-CoV2 in a patient with s lymphoma. Acta Biomed. 2020;91(3):1\u20133.","journal-title":"Acta Biomed"},{"key":"704_CR26","first-page":"1","volume":"2022","author":"M Barkhordar","year":"2022","unstructured":"Barkhordar M, Rostami FT, Yaghmaie M, Abbaszadeh M, Chahardouli B, Mousavi SA. Spontaneous complete remission of acute myeloid leukemia in the absence of Disease-Modifying therapy following severe pulmonary involvement by coronavirus infectious Disease-19. Case Rep Hematol. 2022;2022:1\u20136.","journal-title":"Case Rep Hematol"},{"key":"704_CR27","doi-asserted-by":"publisher","first-page":"175883592110114","DOI":"10.1177\/17588359211011455","volume":"13","author":"A Ottaiano","year":"2021","unstructured":"Ottaiano A, Scala S, D\u2019Alterio C, Trotta A, Bello A, Rea G, Picone C, Santorsola M, Petrillo A, Nasti G. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Ther Adv Med Oncol. 2021;13:17588359211011455.","journal-title":"Ther Adv Med Oncol"},{"key":"704_CR28","unstructured":"Heathbeat. COVID-19 virus could attack cancer cells and shrink tumors, new study suggests | Fox News [Internet]. 2024 [cited 2024 Dec 9]. Available from: https:\/\/www.foxnews.com\/health\/covid-19-virus-could-attack-cancer-cells-shrink-tumors-new-study-suggests"},{"key":"704_CR29","doi-asserted-by":"crossref","unstructured":"Liu X, Budinger GRS, Bharat A, Liu X, Ren Z, Tan C, et al. Regres cancer metastasis inducible CCR2 + nonclassical monocytes mediate regres cancer metastasis. 2024;134(22).","DOI":"10.1172\/JCI179527"},{"key":"704_CR30","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.htct.2021.10.175","volume":"43","author":"AA Paz","year":"2021","unstructured":"Paz AA, Condori XPH, Hofmann AA, et al. SARS-CoV-2 induced remission of diffuse large b-cell lymphoma: a case report. Hematol Transfus Cell Ther. 2021;43:S103.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"704_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.htct.2022.01.017","volume":"44","author":"RL Baptista","year":"2022","unstructured":"Baptista RL, Moreira R, Rego E. COVID-19 induced follicular lymphoma remission. Hematol Transfus Cell Ther. 2022;44(2):291\u20132.","journal-title":"Hematol Transfus Cell Ther"},{"key":"704_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.omto.2022.06.006","volume":"26","author":"DH Shin","year":"2022","unstructured":"Shin DH, Gillard A, Van Wieren A, Gomez-Manzano C, Fueyo J. Remission of liquid tumors and SARS-CoV-2 infection: A literature review. Mol Ther Oncolytics. 2022;26:135\u201340.","journal-title":"Mol Ther Oncolytics"},{"issue":"4","key":"704_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.htct.2023.11.004","volume":"46","author":"R Pe\u00f1uela","year":"2024","unstructured":"Pe\u00f1uela R, Hernandez I, Fernandes-Pineda M, et al. Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection. Hematol Transfus Cell Ther. 2024;46(4):506\u201310.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"17","key":"704_CR34","doi-asserted-by":"publisher","first-page":"e42039","DOI":"10.1097\/MD.0000000000042039","volume":"104","author":"Y Qi","year":"2025","unstructured":"Qi Y, Li JY, Wang J, Mu J, Deng Q, Cui R. De Novo AML spontaneously achieved PR after COVID-19 infection, and CR after reduced dose of Azacytidine combined with venetoclax: A case report and literature review. Med (Baltim). 2025;104(17):e42039.","journal-title":"Med (Baltim)"},{"issue":"4","key":"704_CR35","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.21037\/jgo-24-59","volume":"15","author":"C Eslinger","year":"2024","unstructured":"Eslinger C, Uson PLS Jr, Nagalo BM, Borad MJ. Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literature. J Gastrointest Oncol. 2024;15(4):1933\u20138.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"704_CR36","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1159\/000541964","volume":"17","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Wang J, Yang K, Jiang M, Zhang B. SARS-CoV-2-Induced remission of chemotherapy resistance B-Cell Non-Hodgkin lymphoma: A case report. Case Rep Oncol. 2024;17(1):1273\u20136. Published 2024 Nov 7.","journal-title":"Case Rep Oncol"},{"issue":"3","key":"704_CR37","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/ijms23031716","volume":"23","author":"E Gusev","year":"2022","unstructured":"Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. 2022;23(3):1716.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"704_CR38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.amjms.2022.05.017","volume":"364","author":"M Alaeddini","year":"2022","unstructured":"Alaeddini M, Etemad-Moghadam S. SARS-Cov-2 infection in cancer patients, susceptibility, outcome and care. Am J Med Sci. 2022;364(5):511\u201320.","journal-title":"Am J Med Sci"},{"key":"704_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cytogfr.2021.10.005","volume":"63","author":"M du Plessis","year":"2022","unstructured":"du Plessis M, Fourie C, Riedemann J, de Villiers WJS, Engelbrecht AM. Cancer and Covid-19: collectively catastrophic. Cytokine Growth Factor Rev. 2022;63:78\u201389.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"704_CR40","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1002\/cam4.5694","volume":"12","author":"H Javid","year":"2023","unstructured":"Javid H, Sharbaf Mashhad A, Yazdani S, Akbari Oryani M, Akbari S, Rezagholinejad N, et al. The role of viruses in cancer development versus cancer therapy: an oncological perspective. Cancer Med. 2023;12(10):11127\u201348.","journal-title":"Cancer Med"},{"key":"704_CR41","doi-asserted-by":"publisher","first-page":"962079","DOI":"10.3389\/fimmu.2022.962079","volume":"13","author":"AJ Kombe Kombe","year":"2022","unstructured":"Kombe Kombe AJ, Biteghe FAN, Ndoutoume ZN, Jin T. CD8\u2009+\u2009T-cell immune escape by SARS-CoV-2 variants of concern. Front Immunol. 2022;13:962079.","journal-title":"Front Immunol"},{"issue":"2","key":"704_CR42","first-page":"144","volume":"58","author":"C Zanza","year":"2022","unstructured":"Zanza C, Romenskaya T, Manetti AC, Franceschi F, La Russa R, Bertozzi G, et al. Cytokine storm in COVID-19: Immunopathogenesis and therapy. Med (Kaunas). 2022;58(2):144.","journal-title":"Med (Kaunas)"},{"key":"704_CR43","doi-asserted-by":"publisher","first-page":"1190379","DOI":"10.3389\/fimmu.2023.1190379","volume":"14","author":"D Shah","year":"2023","unstructured":"Shah D, Soper B, Shopland L. Cytokine release syndrome and cancer immunotherapies \u2013 historical challenges and promising futures. Front Immunol. 2023;14:1190379.","journal-title":"Front Immunol"},{"key":"704_CR44","doi-asserted-by":"publisher","first-page":"24625","DOI":"10.1038\/s41598-024-75718-1","volume":"14","author":"A Serwaa","year":"2024","unstructured":"Serwaa A, Oyawoye F, Owusu IA, et al. In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells. Sci Rep. 2024;14:24625.","journal-title":"Sci Rep"},{"issue":"8","key":"704_CR45","doi-asserted-by":"publisher","first-page":"2305769","DOI":"10.1002\/advs.202305769","volume":"11","author":"S Fernandes","year":"2023","unstructured":"Fernandes S, Cassani M, Cavalieri F, Forte G, Caruso F. Emerging strategies for immunotherapy of solid tumors using Lipid-Based nanoparticles. Adv Sci (Weinh). 2023;11(8):2305769.","journal-title":"Adv Sci (Weinh)"},{"key":"704_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.acr.2019.03.005","volume":"143","author":"C Buchta Rosean","year":"2019","unstructured":"Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the Microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res. 2019;143:255\u201394.","journal-title":"Adv Cancer Res"},{"key":"704_CR47","doi-asserted-by":"publisher","first-page":"14429","DOI":"10.1007\/s00432-023-05244-6","volume":"149","author":"I Bene\u0161ov\u00e1","year":"2023","unstructured":"Bene\u0161ov\u00e1 I, K\u0159\u00ed\u017eov\u00e1 \u013d, Kverka M. Microbiota as the unifying factor behind the hallmarks of cancer. J Cancer Res Clin Oncol. 2023;149:14429\u201350.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"704_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imr.12897","volume":"296","author":"IG Ovsyannikova","year":"2020","unstructured":"Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV\u20102 and COVID\u201019 susceptibility and severity. Immunol Rev. 2020;296(1):205\u201319.","journal-title":"Immunol Rev"},{"key":"704_CR49","doi-asserted-by":"publisher","first-page":"175883592211383","DOI":"10.1177\/17588359221138388","volume":"14","author":"A Ottaiano","year":"2022","unstructured":"Ottaiano A, Santorsola M, Circelli L, Cascella M, Petrillo N, Perri F, Casillo M, Granata V, Ianniello M, Izzo F, Picone C, Correra M, Petrillo A, Sirica R, Misso G, Delrio P, Nasti G, Savarese G, Caraglia M. Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection. Ther Adv Med Oncol. 2022;14:17588359221138388.","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"704_CR50","first-page":"215","volume":"19","author":"H Salmon","year":"2019","unstructured":"Salmon H, Remark R, Gnjatic S, Merad M. Host tissue determinants of tumour immunity. Nat Rev Cancer. 2019;19(4):215\u201327.","journal-title":"Nat Rev Cancer"},{"issue":"19\u201320","key":"704_CR51","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19\u201320):1267\u201384.","journal-title":"Genes Dev"},{"key":"704_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie N, Shen G, Gao W, et al. Neoantigens: promising targets for cancer therapy. Sig Transduct Target Ther. 2023;8:9.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"704_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/imr.12671","volume":"285","author":"JM Cicchese","year":"2018","unstructured":"Cicchese JM, Evans S, Hult C, Joslyn LR, Wessler T, Millar JA, et al. Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology. Immunol Rev. 2018;285(1):147\u201367.","journal-title":"Immunol Rev"},{"issue":"1","key":"704_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/tropicalmed9010013","volume":"9","author":"AA Al-Qahtani","year":"2024","unstructured":"Al-Qahtani AA, Alhamlan FS, Al-Qahtani AA. Pro-Inflammatory and Anti-Inflammatory interleukins in infectious diseases: A comprehensive review. Trop Med Infect Disease. 2024;9(1):13.","journal-title":"Trop Med Infect Disease"},{"key":"704_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.lungcan.2020.05.034","volume":"146","author":"J Rogado","year":"2020","unstructured":"Rogado J, Pangua C, Serrano-Montero G, Obispo B, Marino AM, P\u00e9rez-P\u00e9rez M, et al. Covid-19 and lung cancer: A greater fatality rate? Lung Cancer. 2020;146:19\u201322.","journal-title":"Lung Cancer"},{"issue":"6","key":"704_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-COV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783\u201391.","journal-title":"Cancer Discov"},{"issue":"2","key":"704_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11684-021-0845-6","volume":"15","author":"J Liang","year":"2021","unstructured":"Liang J, Jin G, Liu T, Wen J, Li G, Chen L, et al. Clinical characteristics and risk factors for mortality in cancer patients with COVID-19. Front Med. 2021;15(2):264\u201374.","journal-title":"Front Med"},{"issue":"7","key":"704_CR58","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","volume":"21","author":"J Tian","year":"2020","unstructured":"Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, china: A Multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):893\u2013903.","journal-title":"Lancet Oncol"},{"issue":"7","key":"704_CR59","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","volume":"21","author":"K Yang","year":"2020","unstructured":"Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and covid-19 in Hubei, china: A Multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904\u201313.","journal-title":"Lancet Oncol"},{"key":"704_CR60","doi-asserted-by":"crossref","unstructured":"Meng Y, Lu W, Guo E, Liu J, Yang B, Wu P, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1).","DOI":"10.1186\/s13045-020-00907-0"},{"issue":"1","key":"704_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.htct.2022.10.001","volume":"46","author":"E Eryilmaz-Eren","year":"2024","unstructured":"Eryilmaz-Eren E, Ture Z, Kilin\u00e7-Toker A, Korkmaz S, \u00c7elik \u0130. The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional study. Hematol Transfus Cell Therapy. 2024;46(1):3\u20137.","journal-title":"Hematol Transfus Cell Therapy"},{"issue":"3","key":"704_CR62","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-COV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"issue":"7","key":"704_CR63","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","volume":"31","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894\u2013901.","journal-title":"Ann Oncol"},{"issue":"2","key":"704_CR64","doi-asserted-by":"publisher","first-page":"731","DOI":"10.7150\/thno.51471","volume":"11","author":"AS Pathania","year":"2021","unstructured":"Pathania AS, Prathipati P, Abdul BAA, Chava S, Katta SS, Gupta SC, et al. Covid-19 and cancer comorbidity: therapeutic opportunities and challenges. Theranostics. 2021;11(2):731\u201353.","journal-title":"Theranostics"},{"issue":"3","key":"704_CR65","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jac\/dks512","volume":"68","author":"EJ Bow","year":"2013","unstructured":"Bow EJ. There should be no escape for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy. J Antimicrob Chemother. 2013;68(3):492\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"704_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1164\/ajrccm.183.2.279b","volume":"183","author":"E Azoulay","year":"2011","unstructured":"Azoulay E, Lambert J, Mokart D. Diagnostic strategy for hematology and oncology patients with acute respiratory failure. Am J Respir Crit Care Med. 2011;183(2):279\u201380.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"704_CR67","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00134-014-3354-0","volume":"40","author":"E Azoulay","year":"2014","unstructured":"Azoulay E, Lemiale V, Mokart D, P\u00e8ne F, Kouatchet A, Perez P, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106\u201314.","journal-title":"Intensive Care Med"},{"issue":"2","key":"704_CR68","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"Y Gao","year":"2020","unstructured":"Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill Covid-19 patients: a review. Allergy. 2020;76(2):428\u201355.","journal-title":"Allergy"},{"issue":"23","key":"704_CR69","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH. Covid-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033\u201340.","journal-title":"Blood"},{"issue":"6","key":"704_CR70","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in\u2010hospital mortality in patients with COVID\u201019. J Thromb Haemost. 2020;18(6):1324\u20139.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"704_CR71","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/jjco\/hyv165","volume":"46","author":"S Ikushima","year":"2015","unstructured":"Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K. Trousseau\u2019s syndrome: Cancer-associated thrombosis. Jpn J Clin Oncol. 2015;46(3):204\u20138.","journal-title":"Jpn J Clin Oncol"},{"issue":"10229","key":"704_CR72","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, china: A retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"7","key":"704_CR73","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934\u201343.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"704_CR74","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829\u201338.","journal-title":"Kidney Int"},{"key":"704_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-020-00177-z","volume":"9","author":"JL Pi\u00f1ana","year":"2020","unstructured":"Pi\u00f1ana JL, Martino R, Garc\u00eda-Garc\u00eda I, Parody R, Morales MD, Benzo G, G\u00f3mez-Catalan I, Coll R, De La Fuente I, Luna A, Merch\u00e1n B, Chinea A, de Miguel D, Serrano A, P\u00e9rez C, Diaz C, Lopez JL, Saez AJ, Bailen R, Zudaire T, Mart\u00ednez D, Jurado M, Calbacho M, V\u00e1zquez L, Garcia-Cadenas I, Fox L, Pimentel AI, Bautista G, Nieto A, Fernandez P, Vallejo JC, Solano C, Valero M, Espigado I, Salda\u00f1a R, Sisinni L, Ribera JM, Jimenez MJ, Trabazo M, Gonzalez-Vicent M, Fern\u00e1ndez N, Talarn C, Montoya MC, Cedillo A, Sureda A. Infectious complications subcommittee of the Spanish hematopoietic stem cell transplantation and cell therapy group (GETH). Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020;9:21.","journal-title":"Exp Hematol Oncol"},{"issue":"10241","key":"704_CR76","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","volume":"395","author":"NM Kuderer","year":"2020","unstructured":"Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL. COVID-19 and cancer Consortium. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907\u201318.","journal-title":"Lancet"},{"issue":"4","key":"704_CR77","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.ccmp.2022.100041","volume":"2","author":"M Ali","year":"2022","unstructured":"Ali M, Wani SUD, Masoodi MH, Khan NA, Shivakumar HG, Osmani RMA, Khan KA. Global effect of COVID-19 pandemic on cancer patients and its treatment: A systematic review. Clin Complement Med Pharmacol. 2022;2(4):100041.","journal-title":"Clin Complement Med Pharmacol"},{"key":"704_CR78","doi-asserted-by":"publisher","first-page":"1260776","DOI":"10.3389\/fmolb.2023.1260776","volume":"10","author":"N Ogarek","year":"2023","unstructured":"Ogarek N, Oboza P, Olszanecka-Glinianowicz M, Kocelak P. SARS-CoV-2 infection as a potential risk factor for the development of cancer. Front Mol Biosci. 2023;10:1260776.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"704_CR79","doi-asserted-by":"publisher","first-page":"e000783","DOI":"10.1136\/esmoopen-2020-000783","volume":"5","author":"M Tagliamento","year":"2020","unstructured":"Tagliamento M, Lambertini M, Genova C, Barisione E, De Maria A, Grosso M, Poggio F, Vagge S, Boccardo F, Pronzato P, Del Mastro L. Call for ensuring cancer care continuity during COVID-19 pandemic. ESMO Open. 2020;5(3):e000783.","journal-title":"ESMO Open"},{"issue":"8","key":"704_CR80","doi-asserted-by":"publisher","first-page":"e2017271","DOI":"10.1001\/jamanetworkopen.2020.17271","volume":"3","author":"T Matsuo","year":"2020","unstructured":"Matsuo T, Kobayashi D, Taki F, Sakamoto F, Uehara Y, Mori N, Fukui T. Prevalence of health care worker burnout during the coronavirus disease 2019 (COVID-19) pandemic in Japan. JAMA Netw Open. 2020;3(8):e2017271.","journal-title":"JAMA Netw Open"},{"key":"704_CR81","doi-asserted-by":"publisher","first-page":"102066","DOI":"10.1016\/j.ajp.2020.102066","volume":"52","author":"RP Rajkumar","year":"2020","unstructured":"Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020;52:102066.","journal-title":"Asian J Psychiatr"},{"key":"704_CR82","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fpsyg.2019.00177","volume":"10","author":"C Ochoa Arnedo","year":"2019","unstructured":"Ochoa Arnedo C, S\u00e1nchez N, Sumalla EC, Casellas-Grau A. Stress and growth in cancer: mechanisms and psychotherapeutic interventions to facilitate a constructive balance. Front Psychol. 2019;10:177.","journal-title":"Front Psychol"},{"issue":"1","key":"704_CR83","first-page":"159","volume":"20","author":"K Tsamakis","year":"2020","unstructured":"Tsamakis K, Triantafyllis AS, Tsiptsios D, Spartalis E, Mueller C, Tsamakis C, Chaidou S, Spandidos DA, Fotis L, Economou M, Rizos E. COVID-19 related stress exacerbates common physical and mental pathologies and affects treatment (Review). Exp Ther Med. 2020;20(1):159\u201362.","journal-title":"Exp Ther Med"},{"issue":"3 Suppl","key":"704_CR84","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.21873\/invivo.11957","volume":"34","author":"G Vanni","year":"2020","unstructured":"Vanni G, Materazzo M, Pellicciaro M, Ingallinella S, Rho M, Santori F, Cotesta M, Caspi J, Makarova A, Pistolese CA, Buonomo OC. Breast cancer and COVID-19: the effect of fear on patients\u2019 Decision-making process. Vivo. 2020;34(3 Suppl):1651\u20139.","journal-title":"Vivo"},{"key":"704_CR85","doi-asserted-by":"publisher","first-page":"175883592110619","DOI":"10.1177\/17588359211061988","volume":"13","author":"A Donia","year":"2021","unstructured":"Donia A, Shahid R, Nawaz M, Yaqub T, Bokhari H. Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells? Ther Adv Med Oncol. 2021;13:17588359211061988.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"704_CR86","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/16078454.2021.1992117","volume":"26","author":"EZ Kandeel","year":"2021","unstructured":"Kandeel EZ, Refaat L, Abdel-Fatah R, Samra M, Bayoumi A, Abdellateif MS, Abdel-Hady H, Ali M, Khafagy M. Could COVID-19 induce remission of acute leukemia? Hematology. 2021;26(1):870\u20133.","journal-title":"Hematology"},{"issue":"1","key":"704_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13691-023-00631-9","volume":"13","author":"M Yasumi","year":"2023","unstructured":"Yasumi M, Yamamoto Y, Kamijo K, Kamae T, Yamato M, Karasuno T. Tumor Lysis syndrome followed by tumor regression after COVID-19 in a patient with chronic lymphocytic leukemia. Int Cancer Conf J. 2023;13(1):22\u20135.","journal-title":"Int Cancer Conf J"},{"issue":"2","key":"704_CR88","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ijc.33213","volume":"148","author":"Y Tian","year":"2021","unstructured":"Tian Y, Qiu X, Wang C, Zhao J, Jiang X, Niu W, Huang J, Zhang F. Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis. Int J Cancer. 2021;148(2):363\u201374.","journal-title":"Int J Cancer"},{"issue":"2","key":"704_CR89","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.gendis.2023.02.052","volume":"11","author":"X Ma","year":"2023","unstructured":"Ma X, Wang Q, Li G, Li H, Xu S, Pang D. Cancer organoids: A platform in basic and translational research. Genes Dis. 2023;11(2):614\u201332.","journal-title":"Genes Dis"},{"key":"704_CR90","doi-asserted-by":"publisher","first-page":"1082191","DOI":"10.3389\/fimmu.2023.1082191","volume":"14","author":"AA Alkayyal","year":"2023","unstructured":"Alkayyal AA, Ajina R, Cacciabue M, Alkayyal AA, Saeedi NH, Hussain Alshehry T, Kaboha F, Alotaibi MA, Zaidan N, Shah K, Alroqi F. Bakur Mahmoud A. SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus. Front Immunol. 2023;14:1082191.","journal-title":"Front Immunol"},{"issue":"6518","key":"704_CR91","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Ant\u00f3n-Pl\u00e1garo C, Shoemark DK, Sim\u00f3n-Gracia L, Bauer M, Hollandi R, Greber UF, Horvath P, Sessions RB, Helenius A, Hiscox JA, Teesalu T, Matthews DA, Davidson AD, Collins BM, Cullen PJ, Yamauchi Y. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861\u20135.","journal-title":"Science"},{"issue":"1","key":"704_CR92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virol.2008.03.002","volume":"376","author":"SU Kapadia","year":"2008","unstructured":"Kapadia SU, Simon ID, Rose JK. SARS vaccine based on a replication-defective Recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. Virology. 2008;376(1):165\u201372.","journal-title":"Virology"},{"issue":"1","key":"704_CR93","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","volume":"11","author":"Y Yahalom-Ronen","year":"2020","unstructured":"Yahalom-Ronen Y, Tamir H, Melamed S, Politi B, Shifman O, Achdout H, Vitner EB, Israeli O, Milrot E, Stein D, Cohen-Gihon I, Lazar S, Gutman H, Glinert I, Cherry L, Vagima Y, Lazar S, Weiss S, Ben-Shmuel A, Avraham R, Puni R, Lupu E, Bar-David E, Sittner A, Erez N, Zichel R, Mamroud E, Mazor O, Levy H, Laskar O, Yitzhaki S, Shapira SC, Zvi A, Beth-Din A, Paran N, Israely T. A single dose of Recombinant VSV-\u2206G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020;11(1):6402.","journal-title":"Nat Commun"},{"key":"704_CR94","doi-asserted-by":"crossref","unstructured":"Dieterle ME, Haslwanter D, Bortz RH 3rd, Wirchnianski AS, Lasso G, Vergnolle O, Abbasi SA, Fels JM, Laudermilch E, Florez C, Mengotto A, Kimmel D, Malonis RJ, Georgiev G, Quiroz J, Barnhill J, Pirofski LA, Daily JP, Dye JM, Lai JR, Herbert AS, Chandran K, Jangra RK. A Replication-Competent vesicular stomatitis virus for studies of SARS-CoV-2 Spike-Mediated cell entry and its Inhibition. Cell Host Microbe. 2020;28(3):486\u2013e4966.","DOI":"10.1016\/j.chom.2020.06.020"},{"key":"704_CR95","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41420-020-0284-1","volume":"6","author":"J Kabiljo","year":"2020","unstructured":"Kabiljo J, Laengle J, Bergmann M. From threat to cure: Understanding of virus-induced cell death leads to highly Immunogenic oncolytic influenza viruses. Cell Death Discov. 2020;6:48.","journal-title":"Cell Death Discov"},{"key":"704_CR96","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fonc.2019.01182","volume":"9","author":"M Abudoureyimu","year":"2019","unstructured":"Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X. Oncolytic Adenovirus-A Nova for Gene-Targeted oncolytic viral therapy in HCC. Front Oncol. 2019;9:1182. Erratum in: Front Oncol. 2020;10:701.","journal-title":"Front Oncol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00704-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00704-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00704-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:03:10Z","timestamp":1761195790000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-025-00704-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00704-9","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}